Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Cash from Financing Activities (2016 - 2025)

Marimed has reported Cash from Financing Activities over the past 12 years, most recently at -$944000.0 for Q4 2025.

  • Quarterly Cash from Financing Activities fell 5.71% to -$944000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.7 million through Dec 2025, down 257.89% year-over-year, with the annual reading at -$4.7 million for FY2025, 257.89% down from the prior year.
  • Cash from Financing Activities was -$944000.0 for Q4 2025 at Marimed, up from -$1.7 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $23.3 million in Q1 2023 and troughed at -$3.1 million in Q3 2023.
  • The 5-year median for Cash from Financing Activities is -$307500.0 (2021), against an average of $1.4 million.
  • Year-over-year, Cash from Financing Activities tumbled 1349.15% in 2022 and then skyrocketed 7176.6% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at -$286000.0 in 2021, then tumbled by 109.79% to -$600000.0 in 2022, then soared by 850.0% to $4.5 million in 2023, then plummeted by 119.84% to -$893000.0 in 2024, then decreased by 5.71% to -$944000.0 in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Cash from Financing Activities are -$944000.0 (Q4 2025), -$1.7 million (Q3 2025), and -$806000.0 (Q2 2025).